Press release
Global In-vitro Inflammatory Bowel Disease Diagnostics Market Forecast 2034: Rising IBD Incidence and Advancements in Non-invasive Testing Drive Market Growth | Transparency Market Research, Inc
In-vitro Inflammatory Bowel Disease Diagnostics Market
Market Overview: Inflammatory Bowel Disease, comprising primarily Crohn's disease and ulcerative colitis, remains a persistent global healthcare challenge due to its chronic nature and debilitating symptoms. Accurate and early diagnosis is critical for disease management, making in-vitro diagnostics (IVD) essential in guiding treatment plans and monitoring disease progression. The surge in laboratory-based and molecular testing methods has contributed to the rapid evolution of this sector.
Gain a preview of important insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=74162
Market Drivers & Trends
The market is fueled by key trends and drivers, notably the development of novel biomarkers, the increasing use of non-invasive testing, and the adoption of point-of-care diagnostics (POCT). Conventional methods such as endoscopy are being gradually supplemented or replaced by less invasive and more efficient diagnostic tools, including fecal biomarkers and molecular assays like PCR and NGS.
The growing prevalence of IBD across both developed and developing regions is pushing the demand for early, accessible, and accurate diagnostics. Additionally, artificial intelligence (AI) and machine learning (ML) are increasingly being integrated into diagnostic platforms, enhancing the analytical power of IVD systems and offering personalized insights based on patient-specific genetic and microbiome data.
Latest Market Trends
• Companion Diagnostics: Tailored diagnostics to complement personalized treatment regimens are on the rise, particularly for biologic therapies.
• Fecal Biomarkers: Tools like calprotectin, CRP, FIT, and Lactoferrin are revolutionizing IBD testing due to their high specificity and ease of collection.
• Lab Automation: High-throughput diagnostic laboratories employing automated analyzers are improving result turnaround and reliability.
• Point-of-Care Testing (POCT): Increasing use of POCT is enabling decentralized testing, improving access, especially in resource-limited settings.
Key Players and Industry Leaders
Several prominent players dominate the global IBD diagnostics market:
• F. Hoffmann-La Roche Ltd
• Thermo Fisher Scientific Inc.
• Abbott
• SENTINEL Diagnostic
• BTNX, Inc.
• Immundiagnostik AG
• Quest Diagnostics
• Sysmex SE
• DiaSorin S.p.A
• Biosystems S.A.
• Quidel Corporation
• Eiken Chemical Co., Ltd.
These companies are actively pursuing R&D, product launches, and strategic partnerships to expand their diagnostic capabilities and market reach.
Recent Developments
• October 2021: Roche signed a definitive acquisition agreement with Telavant for RVT-3101, a novel TL1A-directed antibody aimed at treating IBD. This move solidifies Roche's position in targeted therapy for gastrointestinal conditions.
• June 2022: SENTINEL Diagnostics introduced the SENTiFIT 800 Analyzer, specifically designed for automated fecal immunochemical testing (FIT), optimizing colorectal and IBD screening workflows.
These innovations underscore the industry's commitment to technological advancement and expanded diagnostic access.
Market New Opportunities and Challenges
The expanding demand for early diagnosis, patient-centric treatment, and companion diagnostics presents lucrative opportunities for IVD developers. Growth prospects are particularly notable in Asia-Pacific, Latin America, and parts of the Middle East & Africa, where rising IBD awareness and infrastructure development are stimulating market expansion.
However, challenges remain. These include the high cost of advanced diagnostic platforms, limited access in rural regions, and the need for skilled healthcare professionals to interpret complex diagnostic data. Overcoming these obstacles will be key to tapping into underserved markets.
Buy this Premium Research Report and unlock critical data and findings - https://www.transparencymarketresearch.com/checkout.php?rep_id=74162<ype=S
Future Outlook
The future of the in-vitro IBD diagnostics market is promising. Advances in biomarker discovery, AI-powered diagnostic analytics, and wearable and remote testing devices will shape the next generation of IBD diagnostics. The focus will increasingly shift from reactive to preventive and predictive care, enabling clinicians to diagnose earlier, treat more effectively, and monitor more accurately.
The integration of multi-omics technologies, including genomics, proteomics, and metabolomics, is likely to play a crucial role in early IBD detection and prognosis, fostering a shift toward precision medicine in gastroenterology.
Market Segmentation
By Product:
• Assays/Biomarker
o Calprotectin
o Lactoferrin
o Bile Acids
o H. pylori SA
o Pancreatic Elastase
o Others
• Analyzers
By Testing Type:
• Laboratory-based Testing
• Point-of-Care (POC) Testing
• Self-testing Kits
By End-user:
• Diagnostic Laboratories
• Hospitals
• Others (Homecare Testing & Research Institutes)
The laboratory-based testing segment dominates the market due to high accuracy, broad application range, and established clinical reliability. Meanwhile, diagnostic laboratories account for the largest share among end-users owing to their advanced infrastructure and wide availability of specialized testing panels.
Regional Insights
North America leads the global in-vitro IBD diagnostics market, owing to:
• High prevalence of IBD
• Advanced diagnostic infrastructure
• Heavy R&D investment
• Presence of key market players
Europe follows closely due to supportive healthcare policies, widespread adoption of non-invasive diagnostic technologies, and aging population. Emerging markets in Asia Pacific-especially China, India, and Japan-are witnessing rapid market growth due to increasing healthcare access and awareness campaigns.
Why Buy This Report?
• Comprehensive Market Insights: In-depth analysis of market dynamics, segmentation, and regional trends
• Competitive Landscape: Profiles of major players with strategic developments and financials
• Future-Proof Analysis: Forecasts through 2034 with actionable insights for investors, healthcare providers, and manufacturers
• Innovation Tracking: Up-to-date with latest technological breakthroughs and biomarker discoveries
• Customized Segmentation: Detailed breakdown by product, test type, and end-user for strategic planning
Explore Latest Research Reports by Transparency Market Research:
Microbiology Culture Market: https://www.transparencymarketresearch.com/microbiology-culture-market.html
Non-invasive Prenatal Testing Market: https://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html
Medical Radioisotopes Market: https://www.transparencymarketresearch.com/medical-radioisotopes-market.html
Syphilis Immunoassay Diagnostics Market: https://www.transparencymarketresearch.com/syphilis-diagnostics-market.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global In-vitro Inflammatory Bowel Disease Diagnostics Market Forecast 2034: Rising IBD Incidence and Advancements in Non-invasive Testing Drive Market Growth | Transparency Market Research, Inc here
News-ID: 4106910 • Views: …
More Releases from Transparency Market Research
Global Dark Fiber Market Forecast 2024-2034 - Market Size, Drivers, Trends, And …
The global dark fiber market is poised for substantial growth, surging from US$ 6.4 billion in 2023 to an estimated US$ 10.2 billion by 2034, advancing at a CAGR of 4.5% from 2024 to 2034. This growth is driven by the rapid adoption of 5G networks, exponential expansion of data center projects, and escalating demand for low-latency, high-bandwidth connectivity across key industries.
Market Overview: Dark fiber refers to unused optical fiber…
Global Solid-ion Conductors Industry Poised for 11.2% CAGR Growth, Expected to R …
The global solid-ion conductors market, valued at US$ 22.3 million in 2022, is projected to expand steadily at a CAGR of 11.2% from 2023 to 2031, reaching US$ 46.8 million by the end of 2031. This growth is primarily driven by rising demand for electric vehicles (EVs) and the expansion of the electrical & engineering sector, as technological advancements continue to improve the performance and safety of next-generation energy storage…
Blood Collection Tubes Market Expected to Surpass USD 3.6 Billion by 2032 from U …
The global blood collection tubes market, valued at US$ 2.3 billion in 2023, is projected to reach US$ 3.6 billion by the end of 2032, expanding at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2032. The market's growth is primarily driven by an increase in the prevalence of chronic diseases, a rising number of surgeries, and the growing popularity of EDTA tubes, which are essential in…
Seborrheic Keratosis Treatment Market to Surpass USD 4.5 Billion by 2035, Driven …
The global Seborrheic Keratosis Treatment Market is poised for steady growth over the next decade, projected to rise from a valuation of US$ 2.5 billion in 2024 to over US$ 4.5 billion by 2035, expanding at a compound annual growth rate (CAGR) of 5.8%. This promising trajectory reflects a confluence of rising aesthetic concerns, increased awareness of dermatological conditions, and continued innovation in non-invasive treatment technologies.
Market Overview: Seborrheic keratosis is…
More Releases for IBD
Ace Therapeutics Unveils Imaging Services for Precise Characterization of IBD An …
Ace Therapeutics launched its translational imaging services specifically designed to accurately characterize Inflammatory Bowel Disease (IBD) animal models.
New York, USA - May 28, 2025 - Ace Therapeutics, a leader in preclinical research solutions, launched its translational imaging solutions specifically designed to accurately characterize Inflammatory Bowel Disease (IBD) animal models. This breakthrough offering empowers researchers with high-resolution, quantitative data to enhance drug development and mechanistic studies.
Image: https://www.getnews.info/uploads/3c0755ac659fa5075e809ffd1b893496.jpg
Imaging techniques play a crucial…
Inflammatory Bowel Disease (IBD) Market Size, Growth Insights, and Future Trends
Inflammatory Bowel Disease (IBD) continues to pose significant challenges for individuals and healthcare systems worldwide. With its increasing prevalence, the demand for effective treatments is driving market growth. The IBD treatment market is projected to grow from USD 19.91 billion in 2023 to USD 33.19 billion by 2032, reflecting a compound annual growth rate (CAGR) of 5.5% during the forecast period.
Download Statistical Data: https://www.towardshealthcare.com/download-statistics/5149
Key Market Highlights
• Crohn's Disease Dominates: Crohn's disease…
Canada Inflammatory Bowel Disease (IBD) Market Size & Growth Analysis Report, 20 …
The Canada IBD market is estimated to grow significantly at a CAGR of around 5.2% during the forecast period. Rising prevalence and incidence of IBD across the country is the major driving factor for the market. Canada has among the highest reported prevalence and incidence rates of IBD across the globe. As per CCC, in 2018, nearly 270,000 Canadians were living with IBD, of which 135,000 individuals with Crohn’s disease,…
Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031
Visiongain has published a new report on Inflammatory Bowel Diseases (IBD) Drug Market Report to 2031: Forecasts by Drug Class (Biologics, Aminosalicylates, Corticosteroids, Antibiotics, Immunomodulators, Others), by Indication (Crohn’s Disease, Ulcerative Colitis), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) AND Regional and Leading National Market Analysis PLUS Analysis of Leading IBD Drug Companies AND COVID-19 Recovery Scenarios.
Global Inflammatory Bowel Disease (IBD) drugs market was valued at US$ US$xx…
US Inflammatory Bowel Disease (IBD) Therapeutics Market Research and Forecast 20 …
The US IBD therapeutics market is estimated to grow significantly at a CAGR of around 4.7% during the forecast period. The factors such as the significant prevalence of IBD such as Crohn’s disease and ulcerative colitis across the country contributing to the market growth. As per the Centers for Disease Control and Prevention (CDC), the prevalence of Crohn’s disease and ulcerative colitis in the US was 201 and 238 per…
Global Inflammatory Bowel Disease (IBD) Therapeutics Market, Share, Trends & For …
The global IBD therapeutics market is estimated to grow significantly at a CAGR of around 5.0% during the forecast period. The rise in the number of IBD such as Crohn's disease and ulcerative colitis is augmenting the growth of the global IBD therapeutics market. The increasing prevalence of IBD results in the need for research for the treatment of IBD and innovations in healthcare systems to manage this complex and…
